Ovid Application Error
Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial. Reid, I. R. *,1,2; Horne, A. M. 1; Mihov, B. 1; Stewart, A. 1; Garratt, E. 1; Wiessing, K. R. 1; Bolland, M. J. 1; Bastin, S. 2; Gamble, G. D. 1 [Article] Journal of Internal Medicine. 286(2):221-229, August 2019.
(Format: HTML)